Yudkin JS (2006) Comment to Gerstein HC, Pogue J, Mann JFE et al (2005) The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia DOI 10.1007/s00125-005-0115-1
Gerstein HC, Yusuf S (1996) Dysglycaemia and risk of cardiovascular disease. Lancet 347:949–950
Article
PubMed
CAS
Google Scholar
Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233–240
PubMed
Article
CAS
Google Scholar
Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1980) Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall Study. Lancet 8183:1373–1376
Article
Google Scholar
DECODE Study Group, European Diabetes Epidemiology Group (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26:688–696
Article
Google Scholar
Lawes CM, Parag V, Bennett DA et al (2004) Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 27:2836–2842
PubMed
Article
CAS
Google Scholar
Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N (2004) Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141:413–420
PubMed
CAS
Google Scholar
Gerstein HC, Pogue J, Mann JF et al (2005) The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 48:1749–1755
Article
PubMed
CAS
Google Scholar
Meigs JB, Nathan DM, D’Agostino RB Sr, Wilson PW (2002) Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 25:1845–1850
PubMed
Article
Google Scholar
Buse JB, Rosenstock J (2005) Prevention of cardiovascular outcomes in type 2 diabetes mellitus: trials on the horizon. Endocrinol Metab Clin North Am 34:221–235
Article
PubMed
Google Scholar